Each JCOIN study brings researchers together with justice and health stakeholders in five or more communities to address gaps in opioid use disorder treatment and related services. Their work engages a wide range of justice settings, including jails, prisons, community corrections, problem-solving courts, and juvenile justice agencies. The studies evaluate behavioral interventions, digital therapeutics, comprehensive patient-centered treatments, and delivery of medications for opioid use disorder (MOUD) throughout the United States.
In 2018-2020, JCOIN supported 15 accelerator supplement projects, which included short-term studies and surveys.
Browse all or use the filtering tools below for more information about JCOIN studies.
An Implementation Process Evaluation for the “Planning Initiative to Build Bridges between Jail and Community-Based Treatment for Opioid Use Disorder” Project (009)
This supplement is to conduct an implementation process evaluation for the Bureau of Justice Assistance (BJA) and Arnold Ventures’ “Planning Initiative to Build Bridges between Jail and Community-Based Treatment for Opioid Use Disorder.” The goal of the 9-month planning initiative is to help 16 communities develop a continuum of care for providing medications for opioid use disorder (MOUDs) in jails and extending services into the community, bridging jails, community corrections, and community treatment providers.
DAT-Optimizing the Impact of Medication Assisted Treatment Interventions in Prison and Jail Settings (008)
This supplement expands on the scientific impact of the parent grant (1R21DA044443-01) by estimating the impact of expanded access to medications for addiction treatment (MAT) in prisons and jails on post-release rates of overdose. Led by Miriam Hospital, this project used agent-based modeling, data collected through the parent study, existing surveillance data in Rhode Island (RI), and recently-published data from similar settings to understand how different MAT interventions in prison and jail setting impact overdose death post-release. Researchers utilized an agent-based model using historical data on overdose fatality rates in RI to forecast the number of opioid overdose fatalities over an eight year period (2017-2025) under four different MAT strategies. State surveillance data from the four years preceding implementation of the comprehensive MAT program (2012-2016) will be used to calibrate the model. In order to compare the different strategies, researchers will calculate and compare the total number of overdose fatalities statewide as well as the number of overdose fatalities among those being released from correctional facilities over the eight year period.
Police-led Opioid Intervention Programs: A Qualitative Examination of Program Models and Participant Experiences (007)
In response to alarming rates of opioid use disorder (OUD) and opioid overdose related deaths across the US, police departments nationwide have partnered with The Police Assisted Addiction Recovery Initiative (PAARI) to design and implement non-arrest substance use programs and initiatives. The first PAARI program, the Gloucester ANGEL program, began in Massachusetts and other communities have adapted the model to address their local needs. The programs are designed to facilitate access to treatment services rather than taking the approach of arresting substance users.
Individuals with opioid use disorder (OUD) who are released from correctional settings are at high risk for overdose, infectious diseases (HIV, hepatitis C), and premature death. A key strategy to address the opioid epidemic among correctional populations is to increase access to medication for addiction treatment (MAT).
This administrative supplement was awarded to the Palo Alto Veterans Institute for Research to survey the Veterans Health Administration (VHA) justice outreach staff and treatment providers about access to opioid use disorder (OUD) pharmacotherapy for justice-involved veterans. The survey was linked with VHA facility-level data to help determine how a core implementation intervention should be tailored to the unique context of each facility to improve access to OUD pharmacotherapy among veterans with justice involvement.
Expanding the use of medications for addiction treatment (MAT) in specialty courts is a national priority of the Office of National Drug Control Policy and Office of Justice Programs (2018). Providing MAT in community settings, for justice-involved clients or family dependency, is especially challenging given that few problem-solving courts provide medical services, few have treatment budgets, most rely upon local treatment resources, and partnerships are challenging. This administrative supplement will assist in understanding two issues: 1) the current utilization of MAT among problem solving courts; and 2) the barriers and facilitators to the utilization of MAT in problem solving court settings.
Despite the widespread evidence demonstrating the effectiveness of medications for addiction treatment (MAT) and the strong recommendations for their use in criminal justice systems, information about what is currently available, accessible, and utilized throughout the criminal justice system is unknown or dated. In response, Chestnut Health Systems was provided a supplement through the parent grant TRIALS Coordinating Center to Reduce Substance Use, HIV Risk Behaviors, & Crime (5U01DA036221-05) to develop and administer a national survey to document the context, relevant laws and policies that affect the ways in which state prisons are able to address the opioid crisis.
Despite the widespread evidence demonstrating the effectiveness of medications for addiction treatment (MAT) and the strong recommendations for their use in criminal justice systems, information about what is currently available, accessible, and utilized throughout the criminal justice system is unknown or dated. Through an administration supplement provided to the parent grant TRIALS Coordinating Center to Reduce Substance Use, HIV Risk Behaviors, & Crime (5U01DA036221-05), Chestnut Health Systems develop and administer a national survey document the context, relevant laws and policies that affect the ways in which jails are able to address the opioid crisis.
This project deployed a unique substance use-specific policy lab called the Drug Outcome Policy Evaluation (DOPE) to better understand the impact of state policies and subsequent health. DOPE expands on the Prescription Drug Abuse Policy System (PDAPS) and the Drug Abuse Policy System (DAPS), which were developed in 2017, to track state policies aimed to address the toll of opioid misuse, and will rank policies or policy features across states and measure their effects on population health.
Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS)
NIDA’s Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS) was a multisite cooperative agreement that launched in 2013 and ended in 2018. JJ-TRIALS was a seven-site cooperative research program designed to identify and test strategies for improving the delivery of evidence-based substance use and HIV prevention and treatment services for justice-involved youth.
The JCOIN Rapid Innovation Grant (J-RIG) program is a rapid-funding mechanism to support small research grants to study newly emerging policies, practices, or interventions that address prevention and treatment of addiction in justice settings. While opioids are a key priority for J-RIG projects, applications may focus more broadly on other substance use issues, particularly substances…